# Milestone Pharmaceuticals Inc.: filings

MIST · Nasdaq · CIK 1408443 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mist.md) · [Financials](/companies/mist/financials.md) · [Filings](/companies/mist/filings.md) · [Insiders](/companies/mist/insiders.md)

## Reports and events: 123 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 127, 8-K 73, 3 26, SC 13G/A 25, 10-Q 23, CORRESP 13, SC 13G 12, UPLOAD 10, 424B5 9, DEFA14A 8, EFFECT 8, S-8 8, 10-K 7, DEF 14A 7, S-3 7, SCHEDULE 13G/A 7, SC 13D/A 6, 4/A 5, ARS 4, D 4, SCHEDULE 13G 4, 10-K/A 3, 144 3, DRS/A 2, DRSLTR 2, SC 13D 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, S-3/A 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-03 | 16:03 ET | [8-K](/filings/0001104659-26-105052.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-105052 |
| 2026-08-12 | 07:28 ET | [8-K](/filings/0001104659-26-094466.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-094466 |
| 2026-08-12 | 07:01 ET | [10-Q](/filings/0001104659-26-094435.md) | Quarterly report, period 2026-06-30 | 0001104659-26-094435 |
| 2026-06-15 | 16:05 ET | [8-K](/filings/0001104659-26-074025.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-074025 |
| 2026-05-13 | 07:23 ET | [8-K](/filings/0001104659-26-059780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059780 |
| 2026-05-13 | 07:04 ET | [10-Q](/filings/0001104659-26-059752.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059752 |
| 2026-04-30 | 16:06 ET | [DEF 14A](/filings/0001104659-26-052880.md) | Proxy statement, period 2026-06-10 | 0001104659-26-052880 |
| 2026-03-20 | 07:25 ET | [8-K](/filings/0001104659-26-032427.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-032427 |
| 2026-03-20 | 07:07 ET | [10-K](/filings/0001104659-26-032415.md) | Annual report, period 2025-12-31 | 0001104659-26-032415 |
| 2026-01-26 | 09:27 ET | [8-K](/filings/0001104659-26-006483.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-006483 |
| 2026-01-13 | 06:06 ET | [8-K](/filings/0001104659-26-003038.md) | 8.01 Other events | 0001104659-26-003038 |
| 2026-01-06 | 08:05 ET | [8-K](/filings/0001104659-26-001099.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-001099 |
| 2025-12-15 | 08:56 ET | [8-K](/filings/0001104659-25-120904.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-120904 |
| 2025-11-12 | 07:16 ET | [8-K](/filings/0001104659-25-109744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109744 |
| 2025-11-12 | 06:56 ET | [10-Q](/filings/0001104659-25-109689.md) | Quarterly report, period 2025-09-30 | 0001104659-25-109689 |
| 2025-08-12 | 07:16 ET | [8-K](/filings/0001104659-25-076468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076468 |
| 2025-08-12 | 06:59 ET | [10-Q](/filings/0001558370-25-011141.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011141 |
| 2025-07-14 | 07:30 ET | [8-K](/filings/0001104659-25-067579.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067579 |
| 2025-07-11 | 06:12 ET | [8-K](/filings/0001104659-25-067108.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067108 |
| 2025-06-16 | 08:06 ET | [8-K](/filings/0001104659-25-059671.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-059671 |
| 2025-06-12 | 16:19 ET | [8-K](/filings/0001104659-25-058874.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-058874 |
| 2025-05-14 | 07:11 ET | [8-K](/filings/0001104659-25-048160.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048160 |
| 2025-05-14 | 07:00 ET | [10-Q](/filings/0001558370-25-007648.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007648 |
| 2025-04-30 | 17:01 ET | [DEF 14A](/filings/0001104659-25-042640.md) | Proxy statement, period 2025-06-10 | 0001104659-25-042640 |
| 2025-03-28 | 07:05 ET | [8-K](/filings/0001104659-25-029047.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029047 |
| 2025-03-19 | 16:05 ET | [8-K](/filings/0001104659-25-025547.md) | 5.08 Item not in the standard list | 0001104659-25-025547 |
| 2025-03-18 | 16:25 ET | [8-K](/filings/0001104659-25-025055.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-025055 |
| 2025-03-13 | 07:18 ET | [8-K](/filings/0001104659-25-023218.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023218 |
| 2025-03-13 | 07:04 ET | [10-K](/filings/0001558370-25-002849.md) | Annual report, period 2024-12-31 | 0001558370-25-002849 |
| 2025-02-25 | 16:05 ET | [8-K](/filings/0001104659-25-016929.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-016929 |
| 2024-11-12 | 09:12 ET | [8-K](/filings/0001104659-24-116493.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116493 |
| 2024-11-12 | 07:02 ET | [10-Q](/filings/0001558370-24-015147.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015147 |
| 2024-09-04 | 08:07 ET | [8-K](/filings/0001104659-24-096648.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-096648 |
| 2024-08-08 | 16:28 ET | [8-K](/filings/0001104659-24-087301.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087301 |
| 2024-08-08 | 16:13 ET | [10-Q](/filings/0001558370-24-011603.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011603 |
| 2024-07-16 | 18:06 ET | [SC 13D/A](/filings/0000921895-24-001575.md) | Ownership report, active investor, amended | 0000921895-24-001575 |
| 2024-07-15 | 16:34 ET | [DEF 14A](/filings/0001104659-24-079878.md) | Proxy statement, period 2024-08-28 | 0001104659-24-079878 |
| 2024-07-15 | 16:02 ET | [8-K](/filings/0001104659-24-079854.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-079854 |
| 2024-05-29 | 07:09 ET | [8-K](/filings/0001104659-24-065806.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-065806 |
| 2024-05-13 | 07:34 ET | [8-K](/filings/0001104659-24-060221.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-060221 |
| 2024-05-13 | 06:59 ET | [10-Q](/filings/0001558370-24-007860.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007860 |
| 2024-04-29 | 17:06 ET | [10-K/A](/filings/0001104659-24-054157.md) | Annual report, amended, period 2023-12-31 | 0001104659-24-054157 |
| 2024-04-08 | 16:38 ET | [8-K](/filings/0001104659-24-044767.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-044767 |
| 2024-03-28 | 07:07 ET | [8-K](/filings/0001104659-24-040008.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-040008 |
| 2024-03-21 | 07:21 ET | [8-K](/filings/0001104659-24-036941.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-036941 |
| 2024-03-21 | 07:01 ET | [10-K](/filings/0001558370-24-003666.md) | Annual report, period 2023-12-31 | 0001558370-24-003666 |
| 2024-03-04 | 09:00 ET | [8-K](/filings/0001104659-24-030267.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-030267 |
| 2024-02-26 | 07:06 ET | [8-K](/filings/0001104659-24-027262.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-027262 |
| 2023-12-26 | 07:15 ET | [8-K](/filings/0001104659-23-128988.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-128988 |
| 2023-11-13 | 07:05 ET | [8-K](/filings/0001104659-23-116646.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-116646 |

Page 1 of 3. [Older](/companies/mist/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.